Trials / Completed
CompletedNCT05371210
An End-to-end System for Assessment and Intervention of Frailty
SAIF: An End-to-end System for Assessment and Intervention of Frailty
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Tan Tock Seng Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to evaluate the feasibility and effectiveness of using SAIF (an end-to-end System for Assessment and Intervention of Frailty) to reduce the risk and delay the progress of physical frailty.
Detailed description
SAIF is a personalised, community-based system for both assessment and intervention of frailty. It comprises of 8 modules categorised into 1. Interface: virtual nurse and caregiver gateway 2. Assessment: computerised screening using Fried Frailty Phenotype (FFP) and FRAIL instruments, Gamified Walking While Talking to assess frailty status and predictive analytics to predict participant's frailty risk 3. Intervention: Physical exercise kiosks (Cycling and Taichi) incorporated with games, polypharmacy management and nutrition recommendation A total of 105 eligible community-dwelling older adults were recruited and randomised either to control arm or intervention arm using a single-consent Zelen's design. Allocation concealment was achieved using permutated block randomisation; both research assistant and participant were blinded to randomisation list during enrolment. All participants completed baseline assessment and subsequent follow-up assessments (2-month, 4-month and 7-month). Additionally, participants in the intervention arm began SAIF interaction for a period of 4 months upon completion of their baseline assessment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | SAIF | Participants interacted with SAIF system at least 2-3 times per week; each session took up to 20 minutes. |
Timeline
- Start date
- 2021-03-15
- Primary completion
- 2022-06-16
- Completion
- 2022-06-16
- First posted
- 2022-05-12
- Last updated
- 2025-12-23
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT05371210. Inclusion in this directory is not an endorsement.